Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy Combined with Immunotherapy and Anti-angiogenic Therapy in Patients with Advanced HER2-negative Breast Cancer：a Single-arm, Exploratory Clinical Study

NCT06890871 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT06890871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06890871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy Combined with Immunotherapy and Anti-angiogenic Therapy in Patients with Advanced HER2-negative Breast Cancer：a Single-arm, Exploratory Clinical Study
Lead sponsor
Zhongnan Hospital
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
August 8, 2024
Completion date
December 31, 2025
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic breast cancer